Clinical trial · Interventional
Diet Effect on Cancer Treatment Outcome
A Study on the Effect Diet Has Affecting the Response of Patients Taking N-111 Who Are on a Vegetarian Diet Vs a Non-vegetarian Diet or a Placebo
NCT05410002CI-TRIAL-00081285completedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study will look at the end result of 2 types of diets effect on treatment outcome of cancer patients using N-111.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Cancer Breast | — | UNRESOLVED | — |
| Cancer Prostate | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Dietary Supplement: N-111 | Dietary Supplement | — | UNRESOLVED |
| Placebo | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (6)
- type
- ACTIVE_COMPARATOR
- label
- Vegetarian N-111 group
- description
- The group will use a vegetarian diet with the active compactor N-111.
- interventionNames
- Dietary Supplement: Dietary Supplement: N-111
- type
- ACTIVE_COMPARATOR
- label
- Non-vegetarian N-111 group.
- description
- The group will use a non-vegetarian diet with the active compactor N-111.
- interventionNames
- Dietary Supplement: Dietary Supplement: N-111
- type
- PLACEBO_COMPARATOR
- label
- Vegetarian placebo group
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 25 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: * A positive diagnosis of breast cancer as determined by Fine Needle Biopsy or open biopsy with associated Cancer Antigen blood markers. * Prostate cancer as determined by a Transrectal Biopsy with associated Prostate- specific antigen blood work. Exclusion Criteria: * •Patients without the positive diagnosis of breast or prostate cancer.
References
Publications (0)
Data not yet available
No reference posted for this study.